Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Current Opinion in Neurology|March 27, 2024
Understanding multiple sclerosis as a disease spectrum: above and below the clinical thresholdStephen Krieger, Karin Cook, Carrie M HershNeurologic Clinics|November 18, 2023
Leveraging Real-World Evidence and Observational Studies in Treating Multiple SclerosisAlbert Aboseif, Izanne Roos, Stephen Krieger, et al.Neurodegenerative Disease Management|October 31, 2022
Updates and advances in multiple sclerosis neurotherapeuticsMoein Amin, Carrie M HershImmunotherapy|April 26, 2014
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosisCarrie M Hersh, Jeffrey A CohenMultiple Sclerosis and Related Disorders|April 11, 2021
How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider surveyElizabeth H Morrison, Katelyn Michtich, Carrie M HershThe Mount Sinai Journal of Medicine, New York|March 23, 2011
Multiple sclerosis therapeutic pipeline: opportunities and challengesStephen KriegerNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 9, 2017
Wellness and the Role of Comorbidities in Multiple SclerosisBrandon P Moss, Mary R Rensel, Carrie M HershMultiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimodCarrie M Hersh, Haleigh Harris, Malissa Ayers, et al.Neurology. Clinical Practice|January 29, 2021
Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practiceCarrie M Hersh, Haleigh Harris, Devon Conway, et al.Journal of Health Service Psychology|January 31, 2023
Leadership Inequity, Burnout, and Lower Engagement of Women in MedicineAmy B Sullivan, Carrie M Hersh, Mary Rensel, et al.Pageof 10